Erythropoietin prevents the development of interleukin-12-induced anemia and thrombocytopenia but does not decrease its antitumor activity in mice.
Gołab
J
J
Zagozdzon
R
R
Stokłosa
T
T
Jakóbisiak
M
M
Pojda
Z
Z
Machaj
E
E
D000740:Anemia / Q000139:chemically induced* / Q000517:prevention & control*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004347:Drug Interactions; D004921:Erythropoietin / Q000494:pharmacology*; D006454:Hemoglobins / Q000032:analysis; D018664:Interleukin-12 / Q000494:pharmacology*; D051379:Mice; D010976:Platelet Count / Q000187:drug effects; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000517:prevention & control*; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D006454:Hemoglobins; D004921:Erythropoietin; D018664:Interleukin-12